Crown Bioscience partners with Turbine to accelerate translational oncology research
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
Subscribe To Our Newsletter & Stay Updated